Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section

Recruiting now · Not applicable

Conditions studied: Cesarean Section, Local Anesthetic

In brief

This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections

Key facts

Study ID

NCT06376058

Run by

Aretaieion University Hospital

People needed

60

Starts

2024-01-10

Expected to finish

2026-01-10

Last updated by the study team

2025-07-22

Who can join

Age: 18 and older, up to 48. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• adult parturients, American Society of Anesthesiologists (ASA) I-II,
• singleton gestation>37 weeks
• elective cesarean section

You may not qualify if…

• American Society of Anesthesiologists (ASA) > III
• age < 18 years
• singleton gestation <37 weeks
• Body Mass Index (BMI) >40 kg/m2
• Body weight <50 kg
• Body weight>100 kg
• height<150 cm
• height>180 cm
• multiple gestation
• emergency delivery
• fetal abnormality
• fetal distress
• pregnancy-induced pathology such as preeclampsia, eclampsia, premature labor, placental abnormalities
• pregnancy- induced diseases such as hepatic failure, pseudocholinesterase deficiency, neuromuscular diseases
• lack of informed consent
• contraindication for regional anesthesia such as thrombocytopenia, coagulation abnormalities, allergy to local anesthetics

Where it is running

• Aretaieion University Hospital — Athens, Greece (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.